Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3- Gallate Encapsulated in Chitosan Nanoparticles on Human Prostate Carcinoma Cells
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2014, Vol 2, Issue 1
Abstract
(-)-epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, has shown excellent effects in preventing, as well as treating, many cancers including prostate cancer (PCa) in preclinical model systems. However its applicability to humans has met with limited success due to several issues including its limited bioavailability. We employed the use of nanotechnology to improve the outcome of cancer chemoprevention and coined the concept ‘nanochemoprevention’. Recently, we reported the synthesis, characterization and efficacy assessment of a formulation of chitosan encapsulating EGCG (Chit-nanoEGCG) for treatment of PCa in a xenograft model [1]. Here we show the efficacy of this nanoformulation in human PCa cells for inhibition of cell growth, induction of apoptosis, and inhibition of the colony formation. We further demonstrate that the encapsulated EGCG retains its mechanistic identity for induction of apoptosis. We observed that chit- nanoEGCG treatment induces apoptosis and also results in growth arrest of the cells in S phase and the cell cycle-regulatory molecules operative in the G1/S phase of the cell cycle were significantly modulated. All these effects were seen at much lower doses in chit-nanoEGCG treated cells as compared to the native agent. Collectively, chit- nanoEGCG could prove useful for preventing and/or treating human PCa.
Authors and Affiliations
Hasan Mukhtar
Keywords
Related Articles
- EP ID EP197912
- DOI 10.13188/2327-204X.1000007
- Views 88
- Downloads 0
Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
Fatty acid amide hydrolase (FAAH), the enzyme involved in the inactivation of the endocannabinoid anandamide (AEA), is being considered as a therapeutic target for analgesia and neuroprotection. We have developed a brain...
Mathematical Model of Pharmacokinetic Behavior of Orally Administered Prednisolone in Healthy Volunteers
The objective of the current study was to develop mathematical models that described the pharmacokinetic behavior of prednisolone in healthy subjects after the oral administration of prednisolone. The current study is a...
Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats
Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...
Instability of Cefpodoxime Proxetil Oral Suspension at Different Temperature Storage Conditions
The advantages of oral dosage form over other dosage forms are responsible for its popularity which includes its ease of administration, patient compliance and stability of the formulation. This study compared the stabil...
Three Examples Illustrating the Good Performance of an Advanced Mathematical Modeling Method Based on the Theory of Dynamic Systems in Pharmacokinetics
The objective of the current study is to give three examples illustrating the good performance of an advanced mathematical modeling method based on the theory of dynamic systems in pharmacokinetics. The performance of th...